HealthStream Announces Fourth Quarter & Full Year 2013 Results
Highlights:
Fourth Quarter
-
Revenues of
$37.1 million in the fourth quarter of 2013, up 33% from$27.8 million in the fourth quarter of 2012 -
Operating income of
$3.5 million in the fourth quarter of 2013, up 5% from$3.3 million in the fourth quarter of 2012 -
Net income of
$1.8 million in both the fourth quarter of 2013 and the fourth quarter of 2012, and earnings per share (EPS) of$0.06 per share (diluted) in the fourth quarter of 2013, compared to$0.07 per share (diluted) in the fourth quarter of 2012 -
Adjusted EBITDA1 of
$5.9 million in the fourth quarter of 2013, up 7% from$5.5 million in the fourth quarter of 2012
Full Year
-
Revenues of
$132.3 million for 2013, up 28% from$103.7 million in 2012 -
Operating income of
$14.7 million in 2013, up 9% from$13.5 million in 2012 -
Net income of
$8.4 million in 2013, up 10% from$7.6 million in 2012, and EPS of$0.30 per share (diluted) for 2013, compared to$0.28 per share (diluted) in 2012 -
Adjusted EBITDA1 of
$23.9 million in 2013, up 13% from$21.2 million in 2012 -
3.39 million healthcare professional subscribers fully implemented on
one or more of our subscription-based solutions at
December 31, 2013 , up 15% from 2.94 million atDecember 31, 2012
Financial Results:
Fourth Quarter 2013 Compared to Fourth Quarter 2012
Revenues for the fourth quarter of 2013 increased
Revenues from the HealthStream Workforce Development Solutions segment
increased by
Revenues from the
Generally accepted accounting principles (GAAP) require companies to
write down beginning balances of acquired deferred revenue balances as
part of "fair value" accounting as defined by GAAP. During the fourth
quarter of 2013,
Operating income for the fourth quarter of 2013 increased by five
percent to
Net income was approximately
Adjusted EBITDA (which we define as net income before interest, income
taxes, share-based compensation, and depreciation and amortization)
increased by seven percent to
At
Full Year 2013 Compared to Full Year 2012
For 2013, revenues were
Other Business Updates
Updated nomenclature and performance metric: Given the expansion
of HealthStream's suite of solutions over the last several years, we
have updated our metric for indicating our number of subscribers.
Historically, our
We are now reporting the total number of individual end-users of
HealthStream's subscription-based solutions, which will be referred to
as "total subscribers." Each individual end-user who utilizes at least
one
At
Since our "total subscribers" metric encompasses the entire scope of our workforce development solutions, it provides a more comprehensive view of our business than the HLC renewal rate, which is by definition limited solely to HLC subscriptions. Together with the "revenue per implemented subscriber" metric, our "total subscriber" metric provides a more representative means for assessing our workforce development business than the previously reported HLC subscriber and contract value renewal rates.
Retiring HLC renewal metrics: Based on the number of HLC subscribers, our renewal rate was 101 percent in the fourth quarter of 2013. Our renewal rate for the number of HLC subscribers reflects the number of subscribers that were up for renewal in the quarter that chose to renew plus the addition of new subscribers on these accounts, compared to previously contracted amounts. The HLC renewal rate based on subscribers for the fourth quarter of 2013 compares to a renewal rate of 92 percent during the fourth quarter of 2012.
Based on HLC contract value, our renewal rate was 98 percent in the fourth quarter of 2013. Our HLC renewal rate for contract value reflects any pricing adjustment that may occur at renewal along with increases in contract value due to the addition of new subscribers as compared to previously contracted amounts. Our calculation of this renewal rate includes only the base subscriptions to our platform; it does not include the purchase of additional products or content purchased prior to or at the time of renewal. The HLC renewal rate based on contract value for the fourth quarter of 2013 compares to a renewal rate of 96 percent during the fourth quarter of 2012.
For the trailing four quarters ended
Annualized revenue per implemented subscriber: "Annualized Revenue per Implemented Subscriber" is a measure of our progress in growing the value of our customer base. Annualized Revenue per Implemented Subscriber represents the quarter's revenue from our subscription-based solutions annualized, then divided by the quarter's average total number of implemented subscribers. The following table shows the metric for the fourth quarter of 2013 and the preceding seven quarters.
Workforce Development Solutions - Annualized Revenue per Implemented Subscriber |
|||||||||||||||||||||||||||
Q1 |
Q2 |
Q3 |
Q4 |
Q1 |
Q2 |
Q3 |
Q4 |
||||||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||||||
Note: Our subscription-based solutions include subscriptions to our platform applications, plus courseware/content subscriptions. The above metric does not include revenues from SimCenter. The Company reports those revenues separately as part of our SimVentures collaborative arrangement.
Update on ICD-10 Training Solution: The requirement mandated by
CMS for healthcare organizations to transition to the ICD-10 coding
system goes into effect in
Financial Outlook for 2014
The Company anticipates that consolidated revenues for full year 2014
will grow by 22 percent to 26 percent as compared to 2013. We anticipate
revenue growth in the Workforce Development Solutions segment to be in
the 23 percent to 27 percent range and the Research / Patient Experience
Solutions segment's revenue to increase by approximately 18 percent to
22 percent, part of which growth includes revenues from the BLG
acquisition which we closed in
We anticipate that the Company's 2014 full-year operating income will increase approximately 10 to 15 percent over full-year 2013. Similar to our revenue guidance, this estimate does not include the impact from any other transactions that we may complete during 2014.
We anticipate that our 2014 capital expenditures will be between
"We are well positioned to make strategic investments in 2014 that we believe will deliver significant value to our customers and that, in turn, will position us for long-term growth," said Frist. "I look forward to reporting continued progress throughout 2014 as we execute our business strategy and strive to deliver superior results for all of our stakeholders."
A conference call with
Use of Non-GAAP Financial Measures
This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing the Company's financial results and ongoing operational performance.
In order to better assess the Company's financial results, management believes that income before interest, income taxes, share-based compensation, depreciation and amortization ("adjusted EBITDA") is an appropriate measure for evaluating the operating performance of the Company because adjusted EBITDA reflects net income adjusted for non-cash and non-operating items. Adjusted EBITDA is also used by many investors to assess the Company's results from current operations. Adjusted EBITDA is a non-GAAP financial measure and should not be considered as a measure of financial performance under GAAP. Because adjusted EBITDA is not a measurement determined in accordance with GAAP, it is susceptible to varying calculations. Accordingly, adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies.
Recently the Company has acquired businesses whose net tangible assets include deferred revenue. In accordance with GAAP reporting requirements, the Company may record a write down of deferred revenue to fair value as defined in GAAP. If the Company is required to record a write-down of deferred revenue, it may result in lower recognized revenue. In order to provide more accurate trends and comparisons of the Company's revenues, operating income, and net income, management believes that adding back the deferred revenue write-down associated with fair value accounting for acquired businesses provides a better indication of the ongoing performance of the Company. Both on a quarterly and year-to-date basis, the revenue for the acquired business is deferred and typically recognized over a one-year period, so our GAAP revenues for the one-year period after the acquisition will not reflect the full amount of revenues that would have been reported if the acquired deferred revenue was not written down to fair value.
These non-GAAP financial measures should not be considered as a substitute for, or superior to, measures of financial performance which are prepared in accordance with GAAP and may be different from non-GAAP financial measures used by other companies. Investors are encouraged to review the reconciliations of our GAAP to non-GAAP financial measures, which are set forth below in this release.
About
1 Adjusted EBITDA is a non-GAAP financial measure. A reconciliation of adjusted EBITDA to net income is included in this release.
Summary Financial Data (In thousands, except per share data) |
||||||||||||||||
Three Months Ended
|
Year Ended
|
|||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||
Revenues | $ | 37,050 | $ | 27,838 | $ | 132,274 | $ | 103,732 | ||||||||
Operating expenses: | ||||||||||||||||
Cost of revenues (excluding depreciation and amortization) |
16,123 |
11,112 |
55,605 |
41,658 |
||||||||||||
Product development | 3,162 | 2,282 | 11,757 | 8,610 | ||||||||||||
Sales and marketing | 7,514 | 5,255 | 24,052 | 19,892 | ||||||||||||
Other general and administrative | 4,702 | 3,961 | 18,342 | 13,452 | ||||||||||||
Depreciation and amortization | 2,040 | 1,882 | 7,852 | 6,661 | ||||||||||||
Total operating expenses |
33,541 | 24,492 | 117,608 | 90,273 | ||||||||||||
Operating income | 3,509 | 3,346 | 14,666 | 13,459 | ||||||||||||
Other income | 55 | 31 | 176 | 118 | ||||||||||||
Income before income taxes | 3,564 | 3,377 | 14,842 | 13,577 | ||||||||||||
Income tax provision | 1,804 | 1,556 | 6,424 | 5,932 | ||||||||||||
Net income | $ | 1,760 | $ | 1,821 | $ | 8,418 | $ | 7,645 | ||||||||
Net income per share: | ||||||||||||||||
Net income per share, basic | $ | 0.06 | $ | 0.07 | $ | 0.31 | $ | 0.29 | ||||||||
Net income per share, diluted | $ | 0.06 | $ | 0.07 | $ | 0.30 | $ | 0.28 | ||||||||
Weighted average shares outstanding: | ||||||||||||||||
Basic | 27,264 | 26,212 | 26,853 | 26,128 | ||||||||||||
Diluted | 27,858 | 27,600 | 27,663 | 27,507 |
Condensed Consolidated Balance Sheets (In thousands) |
||||||||||
Unaudited | ||||||||||
|
|
|||||||||
2013 |
2012(1) |
|||||||||
ASSETS | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | $ | 59,537 | $ | 41,365 | ||||||
Marketable securities - short term | 48,659 | 51,952 | ||||||||
Accounts and unbilled receivables, net | 26,706 | 16,511 | ||||||||
Prepaid and other current assets | 12,222 | 6,004 | ||||||||
Deferred tax assets, current | -- | 2,459 | ||||||||
Total current assets | 147,124 | 118,291 | ||||||||
Capitalized software development, net | 11,077 | 9,732 | ||||||||
Property and equipment, net | 9,038 | 7,820 | ||||||||
Goodwill and intangible assets, net | 44,616 | 38,104 | ||||||||
Other assets | 739 | 581 | ||||||||
Total assets | $ | 212,594 | $ | 174,528 | ||||||
LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||
Current liabilities: | ||||||||||
Accounts payable, accrued and other liabilities | $ | 18,044 | $ | 11,886 | ||||||
Deferred revenue | 38,168 | 23,146 | ||||||||
Total current liabilities | 56,212 | 35,032 | ||||||||
Deferred tax liabilities, non-current |
6,173 |
6,474 |
||||||||
Other long-term liabilities | 776 | 826 | ||||||||
Total liabilities | 63,161 | 42,332 | ||||||||
Shareholders' equity: | ||||||||||
Common stock | 166,888 | 158,020 | ||||||||
Comprehensive income (loss) | (31 | ) | 18 | |||||||
Accumulated deficit | (17,424 | ) | (25,842 | ) | ||||||
Total shareholders' equity | 149,433 | 132,196 | ||||||||
Total liabilities and shareholders' equity | $ | 212,594 | $ | 174,528 | ||||||
(1) Derived from audited financial statements contained in the
Company's filing on Form 10-K for the year ended |
||||||||||
Condensed Consolidated Statement of Cash Flows (In thousands) |
||||||||||
Year Ended | ||||||||||
|
|
|||||||||
2013 | 2012 | |||||||||
Operating activities: | ||||||||||
Net income | $ | 8,418 | $ | 7,645 | ||||||
Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||
Depreciation and amortization | 7,852 | 6,661 | ||||||||
Deferred income taxes | 2,506 | 5,601 | ||||||||
Share-based compensation | 1,458 | 1,136 | ||||||||
Excess tax benefits from equity awards | (3,722 | ) | (111 | ) | ||||||
Provision for doubtful accounts | 115 | 120 | ||||||||
Other | 1,696 | 738 | ||||||||
Changes in assets and liabilities: | ||||||||||
Accounts and unbilled receivables | (10,056 | ) | 1,227 | |||||||
Prepaid and other assets | (6,220 | ) | (881 | ) | ||||||
Accounts payable, accrued and other liabilities | 9,475 | 592 | ||||||||
Deferred revenue | 14,761 | (198 | ) | |||||||
Net cash provided by operating activities | 26,283 | 22,530 | ||||||||
Investing activities: | ||||||||||
Acquisitions, net of cash acquired | (7,560 | ) | (9,901 | ) | ||||||
Changes in marketable securities | 1,584 | (40,101 | ) | |||||||
Investments in non-marketable equity investments | (300 | ) | (250 | ) | ||||||
Purchases of property and equipment | (4,444 | ) | (4,316 | ) | ||||||
Payments associated with capitalized software development | (4,267 | ) | (4,435 | ) | ||||||
Net cash used in investing activities | (14,987 | ) | (59,003 | ) | ||||||
Financing activities: | ||||||||||
Proceeds from exercise of stock options | 3,318 | 823 | ||||||||
Taxes paid related to net settlement of equity awards | (164 | ) | -- | |||||||
Excess tax benefits from equity awards | 3,722 | 111 | ||||||||
Net cash provided by financing activities | 6,876 | 934 | ||||||||
Net increase (decrease) in cash and cash equivalents | 18,172 | (35,539 | ) | |||||||
Cash and cash equivalents at beginning of period | 41,365 | 76,904 | ||||||||
Cash and cash equivalents at end of period | $ | 59,537 | $ | 41,365 |
Reconciliation of GAAP to Non-GAAP Financial Measures(1) (In thousands, except per share data) |
||||||||||||||||||||
Three Months Ended
|
Year Ended
|
|||||||||||||||||||
2013 | 2012 | 2013 | 2012 | |||||||||||||||||
GAAP net income | $ | 1,760 | $ | 1,821 | $ | 8,418 | $ | 7,645 | ||||||||||||
Interest income | (74 | ) | (58 | ) | (263 | ) | (181 | ) | ||||||||||||
Interest expense | 13 | 10 | 51 | 48 | ||||||||||||||||
Income tax provision | 1,804 | 1,556 | 6,424 | 5,932 | ||||||||||||||||
Share-based compensation expense | 370 | 299 | 1,458 | 1,136 | ||||||||||||||||
Depreciation and amortization | 2,040 | 1,882 | 7,852 | 6,661 | ||||||||||||||||
Adjusted EBITDA | $ | 5,913 | $ | 5,510 | $ | 23,940 | $ | 21,241 | ||||||||||||
GAAP revenues | $ | 37,050 | $ | 27,838 | $ | 132,274 | $ | 103,732 | ||||||||||||
Add: deferred revenue write-down | 172 | 403 | 839 | 490 | ||||||||||||||||
Non-GAAP revenues | $ | 37,222 | $ | 28,241 | $ | 133,113 | $ | 104,222 | ||||||||||||
GAAP operating income | $ | 3,509 | $ | 3,346 | $ | 14,666 | $ | 13,459 | ||||||||||||
Add: deferred revenue write-down | 172 | 403 | 839 | 490 | ||||||||||||||||
Non-GAAP operating income | $ | 3,681 | $ | 3,749 | $ | 15,505 | $ | 13,949 | ||||||||||||
GAAP net income | $ | 1,760 | $ | 1,821 | $ | 8,418 | $ | 7,645 | ||||||||||||
Add: deferred revenue write-down, net of tax | 85 | 218 | 476 | 276 | ||||||||||||||||
Non-GAAP net income | $ | 1,845 | $ | 2,039 | $ | 8,894 | $ | 7,921 | ||||||||||||
(1) This press release contains certain non-GAAP financial measures, including non-GAAP net income, non-GAAP operating income, non-GAAP revenue, and adjusted EBITDA, which are used by management in analyzing its financial results and ongoing operational performance. |
||||||||||||||||||||
This press release includes certain forward-looking statements
(statements other than solely with respect to historical fact),
including statements regarding expectations for the financial
performance for 2014 that involve risks and uncertainties regarding
Chief
Financial Officer
ir@healthstream.com
or
Media:
Vice President,
Investor Relations
mollie.condra@healthstream.com
Source:
News Provided by Acquire Media